Print PDF
Attorneys React to High Court's Gene Patent Ruling
June 13, 2013
Elizabeth Brown

Axinn partner Chad Landmon was quoted in Law360’s article, “Attorneys React To High Court’s Gene Patent Ruling.” In the article, attorneys from leading law firms discuss how the U.S. Supreme Court’s recent ruling that human genes cannot be patented will affect Myriad Genetic Inc.’s patents on isolated DNA associated with an increased risk of breast cancer.

Click here to view article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.